Panax Treatment of 36 Cases of Insomnia.docVIP

 PAGE \* MERGEFORMAT 11 Panax Treatment of 36 Cases of Insomnia [Abstract] Objective To evaluate the Chinese thirty-seven Clinical Treatment of insomnia. Methods open, randomized controlled clinical trials, in line with CCMD-3 diagnostic criteria, 69 patients selected randomly divided into two groups, the treatment group (36 patients) orally at bedtime Chinese thirty-seven side, the control group (33 cases) Compound Zaoren capsule orally at bedtime, every two weeks (one course of treatment were followed up 1, a total of two courses. Pittsburgh Sleep Quality Index (PSQI) assessment of clinical efficacy. Results two group after treatment than before treatment PSQI scores decreased within each group before treatment was significantly (P lt;0.01), compared to the difference between the two groups was statistically significant (P lt;0.01). groups Before treatment, and its treatment in 2 weeks, 4 weeks of treatment comparison, PSQI factor of sleep quality, sleep latency, sleep time, sleep efficiency and daytime function were statistically significant differences in points (P lt;0.01, and 4 weeks after treatment, the treatment group sleep time, sleep efficiency improved integration was better than the control group (P lt;0.01. The main side effects: treatment group and control group no adverse reactions. Conclusions Treatment of insomnia Panax effective in increasing sleep efficiency, longer Compound Zaoren sleep is better than capsules, and no obvious side effects. [Keywords:] insomnia, Chinese medicine, Panax side Insomnia is a sleep disorder in one of the most common clinical symptoms, insomnia, according to epidemiological studies have shown that the incidence rate of up to 10% to 20% [1]. At present, the medicine used to treat insomnia, most of the role of strong, quick However, in clinical practice found that the short duration of action of these drugs, medication strength, prone to toxicity and side effects, especially some drugs cause addiction. In